Investigational MRI Clinical Software and Hardware
Launched by NORTHWESTERN UNIVERSITY · Jan 17, 2022
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing new MRI technology, which is a type of imaging used to see inside the body. The goal is to evaluate new scanning techniques that could improve the quality of images we get from MRIs. Researchers are looking for both patients and healthy volunteers to participate in this study, and they are currently recruiting individuals aged 18 and older.
To be eligible, participants must be able to complete a safety questionnaire about MRIs and understand the information provided to them in English. If the MRI involves using a special dye called contrast, healthy volunteers need to have good kidney function (measured by a test called GFR) of at least 60 ml/min, while patients can have a GFR of at least 30 ml/min. People with certain health conditions, such as severe kidney problems or allergies to the contrast dye, cannot participate. If you join the trial, you'll undergo MRI scans, and the process will be explained to you clearly. Your participation could help improve MRI technology for everyone!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • At least 18 years of age
- • Able to complete the MR safety questionnaire.
- • Able to comprehend and provide informed consent in English.
- • When contrast is being administered: healthy volunteers with a GFR≥60 ml/min
- • When contrast is being administered: patients with a GFR ≥30 ml/min
- Exclusion Criteria:
- • • When contrast is being administered: subjects with a GFR \< 30 ml/min
- • When contrast is being administered: subjects with acute kidney injury
- • When contrast is administered, allergy to gadolinium-containing contrast media
- • Contraindication to MRI (implanted device, claustrophobia, dyspnea precluding the ability to follow breath-hold instructions)
- • Adults unable to consent
- • Individuals who are not yet adults
- • Pregnant or breastfeeding women
- • Prisoners
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials